The release of 6-keto-prostaglandin F1α (6-keto-PGF1α) and thromboxane B2 (TXB2, the stable metabolites of prostacyclin (PGI2) and thromboxane A2 (TXA2) during canine acute hemorrhagic pancreatitis (AHP) was studied using four different catheters in order to obtain simultaneous blood samples from (1) the abdominal aorta (2) the inferior vena cava (3) the right atrium of the heart and (4) the portal vein. Splenectomy was performed prior to the induction of AHP, which was performed with a mixture of trypsin and sodium taurocholate infused into the pancreatic duct. Sampling was performed before the induction of AHP (zero value) and thereafter up to 90 min. Plasma 6-keto-PGF1α increased most in the samples collected from the portal vein, and was significantly higher already after 1 min of induction of AHP when compared to the zero value. Plasma TXB2 increased significantly in all sites except in the inferior vena cava. Plasma TXB2 levels decreased rapidly in the portal vein and the right atrium after the induction of AHP, whereas in the abdominal aorta TXB2 levels remained high up to 90 min after induction compared to the zero value. In conclusion, the splanchnic area seems to be the main origin of the released PGI2 during canine AHP and may also have a role in hemodynamic changes observed in AHP due to its vasoactive properties. TXA2 is released from various sources – possibly mainly from the lungs and kidneys during experimental AHP.